|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▲
|
MA Number ▲
|
Registration date ▲
|
Status ▲
|
|
OLIPUDASE ALFA |
A16AB25 |
FR
|
I
|
27-02-2023 |
EMEA/H/C/004850 |
24-06-2022 |
VALID
|
|
P-TOLUENEDIAMINE |
V04CL |
FR
|
I
|
27-02-2023 |
None |
|
VALID
|
|
RELUGOLIX |
L02BX04 |
FR
|
I
|
27-02-2023 |
EMEA/H/C/005353 |
29-04-2022 |
VALID
|
|
RIMEGEPANT |
N02CD06 |
FR
|
I
|
27-02-2023 |
EMEA/H/C/005725 |
25-04-2022 |
VALID
|
|
TEBENTAFUSP |
L01XX75 |
FR
|
I
|
27-02-2023 |
EMEA/H/C/004929 |
01-04-2022 |
VALID
|
|
TEZEPELUMAB |
R03DX11 |
FR
|
I
|
27-02-2023 |
EMEA/H/C/005588 |
19-09-2022 |
VALID
|
|
TIXAGEVIMAB AND CILGAVIMAB |
J06BD03 |
FR
|
I
|
27-02-2023 |
EMEA/H/C/005788 |
25-03-2022 |
VALID
|
|
VOCLOSPORIN |
L04AD03 |
FR
|
I
|
27-02-2023 |
EMEA/H/C/005256 |
15-09-2022 |
VALID
|
|
VUTRISIRAN |
N07XX18 |
FR
|
I
|
27-02-2023 |
EMEA/H/C/005852 |
15-09-2022 |
VALID
|
|
DENGUE VIRUS VACCINES |
J07BX04 |
FR
|
I
|
30-05-2023 |
EMEA/H/C/005155 |
05-12-2022 |
VALID
|
|
DEUCRAVACITINIB |
L04AF07 |
FR
|
I
|
30-05-2023 |
EMEA/H/C/005755 |
24-03-2023 |
VALID
|
|
ETRANACOGENE DEZAPARVOVEC |
B06XX00 |
FR
|
I
|
30-05-2023 |
EMEA/H/C/004827 |
20-02-2023 |
VALID
|
|
GALLIUM (68GA) GOZETOTIDE |
V09IX14 |
FR
|
I
|
30-05-2023 |
EMEA/H/C/005488 |
09-12-2022 |
VALID
|
|
LONCASTUXIMAB TESIRINE |
L01FX22 |
FR
|
I
|
30-05-2023 |
EMEA/H/C/005685 |
20-12-2022 |
VALID
|
|
LUTETIUM (177LU) VIPIVOTIDE TETRAXETAN |
V10XX05 |
FR
|
I
|
30-05-2023 |
EMEA/H/C/005483 |
09-12-2022 |
VALID
|
|
MARALIXIBAT CHLORIDE |
A05AX04 |
FR
|
I
|
30-05-2023 |
EMEA/H/C/005857 |
09-12-2022 |
VALID
|
|
MARIBAVIR |
J05AX10 |
FR
|
I
|
30-05-2023 |
EMEA/H/C/005787 |
09-11-2022 |
VALID
|
|
MITAPIVAT |
B06AX04 |
FR
|
I
|
30-05-2023 |
EMEA/H/C/005540 |
09-11-2022 |
VALID
|
|
NIRMATRELVIR AND RITONAVIR |
J05AE30 |
FR
|
I
|
30-05-2023 |
EMEA/H/C/005973 |
28-01-2022 |
VALID
|
|
NIRSEVIMAB |
J06BD08 |
FR
|
I
|
30-05-2023 |
EMEA/H/C/005304 |
31-10-2022 |
VALID
|
|
RUXOLITINIB |
D11AH09 |
FR
|
I
|
30-05-2023 |
EMEA/H/C/005843 |
19-04-2023 |
VALID
|
|
SPESOLIMAB |
L04AC22 |
FR
|
I
|
30-05-2023 |
EMEA/H/C/005874 |
09-12-2022 |
VALID
|
|
SUTIMLIMAB |
L04AJ04 |
FR
|
I
|
30-05-2023 |
EMEA/H/C/005776 |
15-11-2022 |
VALID
|
|
TABELECLEUCEL |
L01XL09 |
FR
|
I
|
30-05-2023 |
EMEA/H/C/004577 |
16-12-2022 |
VALID
|
|
TREMELIMUMAB |
L01FX20 |
FR
|
I
|
30-05-2023 |
EMEA/H/C/004650 |
20-02-2023 |
VALID
|
|
IRINOTECAN |
L01CE02 |
FR
|
I
|
13-07-2023 |
FR/H/0334/001/ |
17-10-2014 |
VALID
|
|
RIFAMPICIN |
J04AB02 |
FR
|
I
|
13-07-2023 |
|
|
VALID
|
|
FERRIC OXIDE POLYMALTOSE COMPLEXES |
B03AB05 |
FR
|
Not subject to prescription
|
18-07-2023 |
|
|
VALID
|
|
FERROUS SULFATE AND FOLIC ACID |
B03AD03 |
FR
|
Not subject to prescription
|
18-07-2023 |
|
|
VALID
|
|
SODIUM FEREDETATE |
B03AB03 |
FR
|
II
|
18-07-2023 |
|
|
VALID
|
|
BUPRENORPHINE, COMBINATIONS |
N07BC51 |
FR
|
I
|
19-07-2023 |
EMEA/H/C/004407 |
10-11-2017 |
VALID
|
|
COMBINATIONS |
N01BB20 |
FR
|
II + Exemption
|
19-07-2023 |
EMEA/H/C/002693 |
15-11-2013 |
VALID
|
|
PAPAVERINE |
A03AD01 |
FR
|
Not subject to prescription
|
19-07-2023 |
|
|
VALID
|
|
PHOLCODINE |
R05DA08 |
FR
|
Not authorised
|
19-07-2023 |
|
|
VALID
|
|
VARIOUS COMBINATIONS |
B03AE10 |
FR
|
Not subject to prescription
|
19-07-2023 |
|
|
VALID
|
|
VORICONAZOLE |
J02AC03 |
FR
|
I
|
19-07-2023 |
|
|
VALID
|
|
ATOGEPANT |
N02CD07 |
FR
|
I
|
14-11-2023 |
EMEA/H/C/005871 |
11-08-2023 |
VALID
|
|
FUTIBATINIB |
L01EN04 |
FR
|
I
|
14-11-2023 |
EMEA/H/C/005627 |
04-07-2023 |
VALID
|
|
GANAXOLONE |
N03AX27 |
FR
|
I
|
14-11-2023 |
EMEA/H/C/005825 |
26-07-2023 |
VALID
|
|
GLOFITAMAB |
L01FX28 |
FR
|
I
|
14-11-2023 |
EMEA/H/C/005751 |
07-07-2023 |
VALID
|
|
IVOSIDENIB |
L01XM02 |
FR
|
I
|
14-11-2023 |
EMEA/H/C/005936 |
04-05-2023 |
VALID
|
|
MIRIKIZUMAB |
L04AC24 |
FR
|
I
|
14-11-2023 |
EMEA/H/C/005122 |
26-05-2023 |
VALID
|
|
PEGUNIGALSIDASE ALFA |
A16AB20 |
FR
|
I
|
14-11-2023 |
EMEA/H/C/005618 |
04-05-2023 |
VALID
|
|
PIFLUFOLASTAT (18F) |
V09IX16 |
FR
|
I
|
14-11-2023 |
EMEA/H/C/005520 |
24-07-2023 |
VALID
|
|
RESPIRATORY SYNCYTIAL VIRUS VACCINES |
J07BX05 |
FR
|
I
|
14-11-2023 |
EMEA/H/C/006027 |
23-08-2023 |
VALID
|
|
RITLECITINIB |
L04AF08 |
FR
|
I
|
14-11-2023 |
EMEA/H/C/006025 |
15-09-2023 |
VALID
|
|
TALQUETAMAB |
L01FX29 |
FR
|
I
|
14-11-2023 |
EMEA/H/C/005864 |
21-08-2023 |
VALID
|
|
TISLELIZUMAB |
L01FF09 |
FR
|
I
|
14-11-2023 |
EMEA/H/C/005919 |
15-09-2023 |
VALID
|
|
UBLITUXIMAB |
L04AG14 |
FR
|
I
|
14-11-2023 |
EMEA/H/C/005914 |
31-05-2023 |
VALID
|
|
FERRIC MALTOL |
B03AB10 |
FR
|
Not authorised
|
21-11-2023 |
|
|
VALID
|
